Tower Health At Home - Berks Location: 1170 Berkshire Blvd, Wyomissing, Pennsylvania 19610 Ratings: Phone: (610) 378-0481 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Health Calls Location: 1220 Broadcasting Road, Suite 202, Wyomissing, Pennsylvania 19610 Ratings: Phone: (610) 685-2422 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Patient Care Location: 2 Meridian Blvd, Suite 204, Wyomissing, Pennsylvania 19610 Ratings: Phone: (610) 373-0300 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Bayada Home Health Care, Inc. Location: 2 Meridian Boulevard 2nd Floor, Wyomissing, Pennsylvania 19610 Ratings: Phone: (610) 375-3800 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Encompass Health Home Health Location: 1100 Berkshire Blvd Suite 210, Wyomissing, Pennsylvania 19610 Ratings: Phone: (610) 796-6473 Health Services: Nursing Care, Physical Therapy, Occupational Therapy, Speech Pathology, Medical Social Services, Home Health Aide |
Aurora Home Care, Inc Location: 1150 Berkshire Blvd Suite 140, Wyomissing, Pennsylvania 19610 Ratings:NA Phone: (610) 375-1800 Health Services: Nursing Care, Physical Therapy, Speech Pathology, Home Health Aide |
Peritech Home Health Associates, Inc Location: 845 Park Road Suite 302, Wyomissing, Pennsylvania 19610 Ratings:NA Phone: (610) 376-1160 Health Services: Nursing Care, Medical Social Services |
News Archive
A study led by researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health has identified a constellation of metabolites related to myalgic encephalomyelitis/chronic fatigue syndrome.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Oxford Gene Technology, The Molecular Genetics Company, has launched a new version of its Cytocell fluorescence in situ hybridization probes website - designed to provide a wealth of information and advice, offer refined functionality, and be easy-to-use.
A molecular target newly discovered by scientists at two prestigious research institutes may pave the way for new treatments that could combat an aggressive form of leukemia, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
› Verified 8 days ago